UHLMANN PRICE SECURITIES’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Sell
13,592
-269
-2% -$31.5K 0.07% 42
2026
Q1
$1.63M Buy
13,861
+9,724
+235% +$1.12M 0.11% 42
2025
Q4
$435K Buy
4,137
+5
+0.1% +$469 0.26% 98
2025
Q3
$347K Sell
4,132
-948
-19% -$78.1K 0.21% 114
2025
Q2
$402K Buy
5,080
+962
+23% +$76.5K 0.29% 88
2025
Q1
$370K Sell
4,118
-495
-11% -$46.2K 0.27% 92
2024
Q4
$459K Buy
4,613
+1,127
+32% +$116K 0.35% 77
2024
Q3
$396K Buy
+3,486
New +$414K 0.31% 86

Other funds holding MRK

UHLMANN PRICE SECURITIES's MRK Position: Q2 2026 in Review

UHLMANN PRICE SECURITIES reduced its Merck (MRK) stake by 1.9% in Q2 2026, selling an estimated $31.5K and leaving 13,592 shares worth $1.75M. The position accounts for 0.07% of the portfolio, ranked #42.

UHLMANN PRICE SECURITIES first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • UHLMANN PRICE SECURITIES held 13,592 shares of Merck worth $1.75M as of Q2 2026.
  • UHLMANN PRICE SECURITIES sold 269 Merck shares in Q2 2026, an estimated $31.5K.
  • Merck made up 0.07% of UHLMANN PRICE SECURITIES's portfolio in Q2 2026, its #42 holding.
  • UHLMANN PRICE SECURITIES first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on UHLMANN PRICE SECURITIES's 13F filing for Q2 2026, filed 24 Jul 2026.